Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Life Sciences|July 10, 2012
Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociceptionAjay S YekkiralaACS Chemical Biology|May 17, 2013
An immunocytochemical-derived correlate for evaluating the bridging of heteromeric mu-delta opioid protomers by bivalent ligandsAjay S Yekkirala, Alexander E Kalyuzhny, Philip S PortogheseACS Chemical Neuroscience|July 21, 2012
Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonistsAjay S Yekkirala, Alexander E Kalyuzhny, Philip S PortogheseNature Reviews. Drug Discovery|June 10, 2017
Breaking barriers to novel analgesic drug developmentAjay S Yekkirala, David P Roberson, Bruce P Bean, et al.Nature Reviews. Drug Discovery|October 7, 2017
Breaking barriers to novel analgesic drug developmentAjay S Yekkirala, David P Roberson, Bruce P Bean, et al.ACS Chemical Neuroscience|September 29, 2012
Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeysAjay S Yekkirala, Matthew L Banks, Mary M Lunzer, et al.Proceedings of the National Academy of Sciences of the United States of America|March 10, 2011
N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromersAjay S Yekkirala, Mary M Lunzer, Christopher R McCurdy, et al.ACS Chemical Neuroscience|August 4, 2012
The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptorsMatthew D Metcalf, Ajay S Yekkirala, Michael D Powers, et al.Communications Chemistry|August 8, 2025
Optimizing drug design by merging generative AI with a physics-based active learning frameworkIsaac Filella-Merce, Alexis Molina, Lucía Díaz, et al.Communications Biology|December 5, 2023
Bortezomib-induced neuropathy is in part mediated by the sensitization of TRPV1 channelsJared M Sprague, Ajay S Yekkirala, Bhagat Singh, et al.Pageof 2